Merck CEO on Winrevair Approval, Obesity Drug, Health Costs

Wellness Watch
Wellness Watch
256 followers
1 Video View·Mar 28, 2024

Merck Chair and CEO Robert M. Davis discusses the US approval of Winrevair, a new treatment for a rare, dangerous form of high blood pressure. Speaking on Bloomberg Television, Davis also comments on Merck's development of an obesity-fighting drug and health-care costs.